ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Invion Ltd (PK)

Invion Ltd (PK) (IVIXF)

0.0369
0.00
(0.00%)
終了 7月10日 5:00AM

Invion Ltd (PK) (IVIXF) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
0.0369
( - )
買値
0.0123
売値
1.00
出来高
-
平均取引量 (3 か月)
US$ 199,254
財務取引量
-
0.00 日の範囲 0.00
0.0369 52 週間の範囲 0.0369
時価総額
企業価値
4.026M
前日終値
0.0369
始値
-
時刻
最終取引時間
VWAP
-
歳入
-
純利益
-10.5M
発行済株式数
96,965,315
浮動株比率 (%)
54.05%
機関投資家保有比率 (%)
-
配当利回り
PER
-0.26
株価売上高倍率 (PSR)
-
1 株当たり利益 (EPS)
-0.13
ベータ
0.4

Invion Ltd (PK) について

Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-ge... Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical trial to treat non-melanoma skin cancer, as well as for the treatment of oesophageal cancer. The company has collaborations with Hudson Institute of Medical Research, Peter MacCallum Cancer Centre, Dr. I&B Co., Ltd., and Hanlim Pharm Co., Ltd. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia. 詳細を表示

セクター
Healthcare
業界
Pharmaceuticals
ウェブサイト
本社
Melbourne, Australia
設立
2026
Invion Ltd (PK) is listed in the Healthcare sector of the その他OTC with ticker IVIXF. The last closing price for Invion (PK) was US$0.04. Over the last year, Invion (PK) shares have traded in a share price range of US$ 0.0369 to US$ 0.0369.

Invion (PK) currently has 96,965,315 shares in issue. The market capitalisation of Invion (PK) is US$3.58 million. Invion (PK) has a price to earnings ratio (PE ratio) of -0.26.

IVIXF 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
12000.03690.03690.036900CS
26000.03690.03690.036900CS
52000.03690.03690.036910.0369CS
1560.03217680.1268498940.004730.03690.0022124280.00311477CS
2600.026687261.3042201120.0102130.03690.0022217060.01276757CS

IVIXF - Frequently Asked Questions (FAQ)

What is the current Invion Ltd (PK) share price?
The current share price of Invion Ltd (PK) is US$ 0.0369
How many Invion Ltd (PK) shares are in issue?
Invion Ltd (PK) has 96,965,315 shares in issue
What is the market cap of Invion Ltd (PK)?
The market capitalisation of Invion Ltd (PK) is USD 3.58M
What is the 1 year trading range for Invion Ltd (PK) share price?
Invion Ltd (PK) has traded in the range of US$ 0.0369 to US$ 0.0369 during the past year
What is the PE ratio of Invion Ltd (PK)?
The price to earnings ratio of Invion Ltd (PK) is -0.26
What is the registered address of Invion Ltd (PK)?
The registered address for Invion Ltd (PK) is 385 Bourke Street, Melbourne, Victoria, 3000
What is the Invion Ltd (PK) website address?
The website address for Invion Ltd (PK) is www.inviongroup.com
Which industry sector does Invion Ltd (PK) operate in?
Invion Ltd (PK) operates in the Pharmaceuticals sector

IVIXF 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock